Mesenpan: xeno-free, serum-free medium for human mesenchymal stem cells (hMSC) expansion, cell culture media kit (basal medium + growth supplement)

Mesenpan: xeno-free, serum-free medium for human mesenchymal stem cells (hMSC) expansion

P08-50400K
$195.00
$195.00
$231.00
Unavailable
Shipping calculated at checkout.

Introduction

Mesenpan Special Medium is a xeno-free, serum-free medium that was developed especially for proliferation of human mesenchymal stem cells (hMSC) without cell differentiation. It allows a long time culture from hMSC while preserving the differentiation potential in different cell types (multi-lineage potential). To reach a differentiation of the expanded hMSC into different lines, the suitable differentiation factors and protocols should be used.

Mesenpan Special Medium Kit for hMSC without FBS (Cat. No. P08-50400K):

Cell Type: MSCs
Liquid / Powder: liquid
Product Category: Serum-Free Media
Size: 500 ml kit
Sterile: Yes
Manufacturer: PAN-Biotech GmbH
Country of Origin: Germany

Content

The Mesenpan Kit (Cat. No. P08-50400K) consists of:

  • 500 ml Mesenpan Basal Medium
  • 5 ml Mesenpan Growth Supplement.

Composition

Mesenpan contains salts, amino acids, trace elements, hormones and growth factors in an optimized formulation.

Application

Xeno-free, serum-free cultivation and expansion of human mesenchymal stem cells (hMSC) while maintaining their undifferentiated state and multi-lineage potential.

Advantage

Mesenpan is a xeno-free, serum-free complete medium which can be supplemented with 2% FBS or hPL if necessary. Because of the defined composition of the Basal Medium and the Growth Supplement, stable experimental conditions with a high reproducibility of results are achieved without tedious batch-to-batch testing. The addition of suitable reagents after successful expansion allows a differentiation of the MSC in the desired cell type (e.g., bone, cartilage, muscular tissue).

    Storage conditions & stability

    • Mesenpan Basal Medium (P08-50400B): store in the dark at 2-8° C.
    • Mesenpan Growth Supplement (P08-5040S1): store in the dark at -20° C.

    Mesenpan Basal Medium and Mesenpan Growth Supplement are guaranteed stable for 12 months when stored properly. Mesenpan complete medium (Basal Medium + Growth Supplement) is stable for at least 3 months when stored in the dark at 2-8 °C.

    Usage

    This product is intended for Laboratory Research Use Only. Not for use in diagnostic or therapeutic procedures. This product may not be used as a pharmaceutical or veterinary drug, agricultural product, or food additive.

    Documents

    Product References

    • Gonzalez-Rubio, Julian et al. “Pericytes Promote More Vascularization than Stromal Cells via an Interleukin-6-Dependent Mechanism in Microfluidic Chips.” Advanced science (Weinheim, Baden-Wurttemberg, Germany) vol. 12,14 (2025): e2408131. doi:10.1002/advs.202408131
    • Radermacher, Chloé et al. “Various Hydrogel Types as a Potential In Vitro Angiogenesis Model.” Gels (Basel, Switzerland) vol. 10,12 820. 12 Dec. 2024, doi:10.3390/gels10120820
    • Radermacher, Chloé et al. “Impact of compression forces on different mesenchymal stem cell types regarding orthodontic indication.” Stem cells translational medicine vol. 13,10 (2024): 1028-1039. doi:10.1093/stcltm/szae057
    • Sarad, Katarzyna et al. “Senescence of endothelial cells promotes phenotypic changes in adventitial fibroblasts: possible implications for vascular aging.” Molecular and cellular biochemistry vol. 480,2 (2025): 1027-1043. doi:10.1007/s11010-024-05028-7
    • Aveic, Sanja et al. “Three-dimensional in vitro model of bone metastases of neuroblastoma as a tool for pharmacological evaluations.” Nanotheranostics vol. 8,1 1-11. 1 Jan. 2024, doi:10.7150/ntno.85439
    • Castro Nava, Arturo et al. “Actuation of Soft Thermoresponsive Hydrogels Mechanically Stimulates Osteogenesis in Human Mesenchymal Stem Cells without Biochemical Factors.” ACS applied materials & interfaces vol. 16,1 (2024): 30-43. doi:10.1021/acsami.3c11808
    • Brune, Nadine et al. “Dual Labeling of Primary Cells with Fluorescent Gadolinium Oxide Nanoparticles.” Nanomaterials (Basel, Switzerland) vol. 13,12 1869. 16 Jun. 2023, doi:10.3390/nano13121869
    • Nasehi, Ramin et al. “3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model.” Materials today. Bio vol. 19 100596. 28 Feb. 2023, doi:10.1016/j.mtbio.2023.100596
    • Dzhanaev, Robert et al. “Application of the mineral-binding protein fetuin-A for the detection of calcified lesions.” Theranostics vol. 13,2 659-672. 1 Jan. 2023, doi:10.7150/thno.78773
    • Thiebes, Anja Lena et al. “Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio.” Pharmaceutics vol. 14,11 2421. 9 Nov. 2022, doi:10.3390/pharmaceutics14112421
    • Köpf, Marius et al. “Bioprinting-Associated Shear Stress and Hydrostatic Pressure Affect the Angiogenic Potential of Human Umbilical Vein Endothelial Cells.” International journal of bioprinting vol. 8,4 606. 18 Aug. 2022, doi:10.18063/ijb.v8i4.606
    • Luengen, Anja E et al. “Bone Marrow Derived Mesenchymal Stromal Cells Promote Vascularization and Ciliation in Airway Mucosa Tri-Culture Models in Vitro.” Frontiers in bioengineering and biotechnology vol. 10 872275. 17 Jun. 2022, doi:10.3389/fbioe.2022.872275
    • Jatho, Aline et al. “The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells.” Cells vol. 11,4 753. 21 Feb. 2022, doi:10.3390/cells11040753
    • Kniebs, Caroline et al. “Establishment of a Pre-vascularized 3D Lung Cancer Model in Fibrin Gel-Influence of Hypoxia and Cancer-Specific Therapeutics.” Frontiers in bioengineering and biotechnology vol. 9 761846. 14 Oct. 2021, doi:10.3389/fbioe.2021.761846
    • Tsanaktsidou, Evgenia et al. “Biomimetic Cell-Laden MeHA Hydrogels for the Regeneration of Cartilage Tissue.” Polymers vol. 12,7 1598. 18 Jul. 2020, doi:10.3390/polym12071598
    • Kniebs, Caroline et al. “Influence of Different Cell Types and Sources on Pre-Vascularisation in Fibrin and Agarose-Collagen Gels.” Organogenesis vol. 16,1 (2020): 14-26. doi:10.1080/15476278.2019.1697597
    • Duarte Campos, Daniela F et al. “Exploring Cancer Cell Behavior In Vitro in Three-Dimensional Multicellular Bioprintable Collagen-Based Hydrogels.” Cancers vol. 11,2 180. 5 Feb. 2019, doi:10.3390/cancers11020180
    • Ventura Ferreira, Mónica S et al. “Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta.” Stem cell research & therapy vol. 9,1 28. 5 Feb. 2018, doi:10.1186/s13287-017-0757-1
    • Schneider, Rebekka K et al. “Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target.” Cell stem cell vol. 20,6 (2017): 785-800.e8. doi:10.1016/j.stem.2017.03.008

    Related Products

    Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.